Baxter Gets Surprise Setback In Japanese Ultane Ruling

Law360, New York (September 29, 2006, 12:00 AM EDT) -- Heralding a much needed victory for Abbott Laboratories Inc., a Japanese court has ruled that generic drug maker Baxter International Inc. is infringing Abbott’s patent for the popular anesthesia drug Ultane.

The ruling could force Baxter to stop selling the generic in Japan just eight months after the company launched the drug there. Baxter took a risk by launching the drug before the conclusion of parallel litigation in the United States.

The injunction against Baxter was likely handed down by Japan’s new patent court, which was...
To view the full article, register now.